Vistagen to present at the jefferies global healthcare conference

South san francisco, calif.--(business wire)---- $vtgn #mentalhealth--vistagen (nasdaq: vtgn), a late clinical-stage biopharmaceutical company pioneering neuroscience to deliver groundbreaking therapies for individuals affected by psychiatric and neurological disorders, today announced that company management will present and host one-on-one meetings during the jefferies global healthcare conference taking place june 5 and 6, 2024 in new york city. jefferies global healthcare conference shawn singh, chief executive of.
VTGN Ratings Summary
VTGN Quant Ranking